About
ECCO
ECCO General Assembly
ECCO Governing Board
The Council of National Representatives
ECCO Operational Board
SciCom
EduCom
S-ECCO
ClinCom
GuiCom
P-ECCO
EpiCom
N-ECCO
Y-ECCO
H-ECCO
D-ECCO
Committee Podcasts
Affiliate ECCO Societies & ECCO Partners
ECCO Office
ECCO Disclosures
ECCO & IBD
ECCO Elections
Visitors Area
Members Area
Congresses & Events
Future Congresses
15th Congress of ECCO, Vienna 2020
Past Congresses
14th Congress of ECCO, Copenhagen 2019
13th Congress of ECCO, Vienna 2018
12th Congress of ECCO, Barcelona 2017
11th Congress of ECCO, Amsterdam 2016
10th Congress of ECCO, Barcelona 2015
9th Congress of ECCO, Copenhagen 2014
8th Congress of ECCO, Vienna 2013
7th Congress of ECCO, Barcelona 2012
6th Congress of ECCO, Dublin 2011
ECCO Educational Workshops
Event Calendar
Quality Assurance/Endorsement
Membership
Individual Membership
Register/ Renew
Country Members
Corporate Membership
Education
Educational Workshops
e-CCO Learning
IBD Nurse Education Programme
ClinCom Workshop
D-ECCO Workshop
EpiCom Workshop
ECCO-AOCC Forum
ECCO: EduCational COurse for Industry
Guideline Methodology and GRADE Workshop
H-ECCO IBD Masterclass
IBD Intensive Advanced Course
Imaging Workshops
N-ECCO Network Meeting
N-ECCO School
1st Y-ECCO Mentorship Forum
N-ECCO Research Forum
P-ECCO Educational Course
School for Clinical Trialists
SciCom Workshop
S-ECCO IBD Masterclass
Y-ECCO Basic Science Workshop
Science
UR-CARE
Fellowships and Grants
Scientific Workshops
Research Projects
ECCO CONFER Cases
Job postings
Publications
ECCO Topical Review
Published ECCO Topical Reviews
ECCO Guidelines
Published ECCO Guidelines
ECCO e-Guide
Surveys
JCC
JCC Podcasts
ECCO News
Letters from the President
Committee News
Congress News
Literature Reviews
UR-CARE
EU Projects
ECCO Country Member Profiles
ECCO-EFCCA Patient Guidelines
CD Patient Guidelines
UC Patient Guidelines
Congress Abstracts
Abstracts 2019
Abstracts 2018
Abstracts 2017
Abstracts 2016
Abstracts 2015
Abstracts 2014
Abstracts 2013
Abstracts 2012
Abstracts 2011
eNewsletter
ECCO IBD App
Other publications
Public Affairs
Press & Awareness
EU Research Projects
FP7 Sadel Project
Horizon 2020 - BIOCYCLE Project
Publications
Congress Abstracts
Abstracts 2011
Poster presentations: Clinical Diagnosis and outcome (2011)
Search
in the Abstract Database
Search
Abstracts 2011
* = Presenting author
Poster presentations: Clinical Diagnosis and outcome (2011)
P052. Fecal calprotectin is reliable surrogate marker of endoscopic and histologic mucosal healing in Crohn's disease and ulcerative colitis
P053. Is there a change in the natural history of Crohn's disease; Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2008
P054. Serial tuberculin skin tests to detect latent tuberculosis in inflammatory bowel disease patients receiving infliximab therapy
P055. A population-based study: do women with Crohn's disease breastfeed?
P056. Pulmonary function tests in patients with ulcerative colitis
P057. Clinical course of concurrence of inflammatory bowel disease and multiple sclerosis: Results of a national multicentre study [GETAID Group]
P058. Beyond the ordinary diagnostic study: The “real life” accuracy of faecal calprotectin for screening children with suspected inflammatory bowel disease
P059. Development of patient reported outcome (PRO) instruments in ulcerative colitis and Crohn's disease
P060. Does the development of primary sclerosing cholangitis in IBD require the presence of colonic inflammation?
P061. IFN-γ release assay in screening for latent tuberculosis in inflammatory bowel diseases
P062. Serum cytokine profile is related with disease activity in ulcerative colitis patients
P063. Disease extension is the major factor affecting the disease course of ulcerative colitis (UC)
P064. Magnetic resonance enterography for Crohn's disease: Surgical aspects
P065. A tertiary centre experience of vulval Crohn's disease
P066. Diagnostic tests for CMV colitis in inflammatory bowel diseases
P067. Comparison of wireless capsule endoscopy and enteroclysis in the work-out of patients with established and suspected small bowel Crohn's disease
P068. Factors associated with the development of rheumatologic manifestations in patients with ulcerative colitis
P069. Identification of subgroups of adalimumab-treated patients with Crohn's disease who experience high rates of deep remission
P070. Economic impact of deep remission in adalimumab-treated patients with Crohn's disease: Results from EXTEND
P071. Are isolated ileal abnormalities a clinically relevant entity? A retrospective study
P072. Diagnostic medical radiation in inflammatory bowel disease: Primum non-nocere?
P073. A comparative study of clinical, endoscopic and histologic findings in patients with gastrointestinal Behçet's disease and Crohn's disease
P074. Impact of smoking on Crohn's disease clinical course: Data from the multicenter Spanish study “TABACROHN”
P075. Can clinical parameters of disease severity help to predict risk for osteoporosis in inflammatory bowel disease?
P076. Magnetic resonance enterography in adolescents and young adults with Crohn's disease
P077. Diagnostic utility of anti-
Saccharomyces cerevisiae
antibody (ASCA) and interferon-gamma assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis
P078. The first experience in marked mesenchymal stromal cell in Crohn's disease
P079. Level changes of serum anti-glycan antibodies in individual Crohn's disease patients over time
P080. Current European practice in diagnosis and treatment of IBD-associated anaemia
P081. Post surgical recurrence in patients with Crohn's disease: Accuracy of abdominal ultrasonography with oral contrast enhancement performed six months after surgery
P082. Diagnostic accuracy of confocal fluorescence microscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis
P083. Risk factors and impact of
Clostridium difficile
infection in acute severe colitis needing hospitalization
P084. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: A prospective multicenter study
P085. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease
P086. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort
P087. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease
P088. The comparison of three types of capsule endoscopes by small bowel transit time in patients with Crohn's disease
P089. Large burden of disease in early CD-patients in the Biocrohn Registry in Germany
P090. Prospective controlled analysis of vitamin B12 and folate deficiency in Crohn's disease
P091. Longstanding ulcerative colitis related dysplasia – COX-2 and ultrastructural correlations
P092. Usefulness of faecal calprotectin to detect postoperative endoscopic recurrence in Crohn's disease
P093. Impact of magnetic resonance enterography in the management of small bowel Crohn's disease
P094. Adherence with 5-aminosalicylic acid therapy: Results from a large UK pharmacy database
P095. Disaccharidases activity in children with inflammatory bowel disease
P096. Interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD in tube) versus tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
P097. Interferon-gamma release assay or tuberculin skin test in inflammatory bowel disease patients – which is reliable
P098. Serum myeloperoxidase level is a marker of disease activity in patients with inflammatory bowel disease
P099. Systemic AA amyloidosis associated with inflammatory bowel disease
P100. Characteristics of ulcerative colitis associated with autoimmune pancreatitis
P101. Proctocolectomy and ileal pouch anal anastomosis (IPAA) significantly impairs fertility and pregnancy outcomes in ulcerative colitis (UC) patients
P102. Short and long term clinical outcome of infliximab in fulminant ulcerative colitis
P103. Using of confocal endomicroscopy in inflammatory bowel disease of children
P104. Anti-
Saccharomyces cerevisiae
antibodies in Crohn's disease: Role in disease stratification
P105. The individual economic impact of inflammatory bowel disease; The colonic recession
P106. Faecal calprotectin: Useful for clinical differentiation of microscopic colitis and irritable bowel syndrome?
P107. A budget impact model to evaluate medication persistence and associated healthcare costs
P108. Fistulizing pattern is associated with a higher frequency and incidence of cancer in Crohn's disease: A single-center cohort study involving 1288 patients with inflammatory bowel disease
P109. Diagnostic value of magnetic resonance enterography compared with capsule endoscopy in small-bowel mucosal lesions in patients with suspected or established non-obstructive Crohn's disease: A meta-analysis
P110. Validation of a fast genotyping method for analysis of TPMT polymorphisms
P111. Arterial stiffness in patients with inflammatory bowel diseases
P112. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease
P113. Factors affecting Swedish patients' refill adherence and persistence to adalimumab therapy
P114. The diagnostic role of ASCA, Omp-C and atypical pANCA in Indian Asian patients with inflammatory bowel disease
P115. Diastolic dysfunction and its relation with insulin resistance in patients with inflammatory bowel disease
P116. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from Western Hungary, 1977–2008
P117. Evaluation of stress in inflammatory bowel disease patients
P118. Previous misdiagnosis and diagnostic delay in inflammatory bowel diseases
P119. Bone mineral density in Portuguese patients with Crohn's disease
P120. Magnetic resonance enterography (MRE) in children with Crohn's disease: Results from the Belgian Pediatric Crohn's Registry (Belcro)
P121. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study
P122. Extraintestinal manifestations in a single centre cohort of chronic inflammatory bowel disease patients
P123. Accuracy of endoscopic capsule in Crohn's disease diagnosis in an experienced unit
P124. Frequency of opportunistic virus infections in patients with inflammatory bowel diseases in Moscow region
P125. Prevalence of metabolic syndrome in a Turkish population with inflammatory bowel disease
P126. Relationship between cytokine profile and local immunity in ulcerative colitis
P127. Diagnosis of latent tuberculosis in patients with inflammatory bowel disease: Prospective comparison between tuberculin skin test and IGRA test QuantiFERON TB-Gold
®
P128. Serum IL8 concentration improves clinical activity index in ulcerative colitis
P129. Evaluation of fecal calprotectin level in patients with chronic inflammatory bowel diseases
P130. Correlation between serological biomarkers and clinical activity in patients with inflammatory bowel disease (IBD)
P131. The lack of CRP response in patients with non-colonic active Crohn's disease
P132. Thromboembolic complications in inflammatory bowel disease patients: Prevalence in a tertiary referral center
P133. K-ras, Cox-2 and membrane β-catenin positivity are characteristics of tumor-free mucosa in patients with ulcerative colitis-associated colorectal cancer
P134. A change in the attention to patients with inflammatory bowel disease: An integrated care unit
P135. 8-year experience of enterocutaneous fistulae at a national intestinal failure centre